ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $579,390 | -7.1% | 93,000 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $624,000 | +5.4% | 93,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $592,000 | +37.0% | 93,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $432,000 | -7.3% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $466,000 | -95.0% | 93,000 | -74.1% | 0.00% | -90.0% |
| Q4 2020 | $9,328,000 | -30.1% | 358,800 | 0.0% | 0.04% | -52.4% |
| Q3 2020 | $13,336,000 | -2.5% | 358,800 | +34.6% | 0.08% | -27.6% |
| Q2 2020 | $13,680,000 | +158.2% | 266,600 | +123.3% | 0.12% | +314.3% |
| Q3 2018 | $5,298,000 | +13.2% | 119,400 | 0.0% | 0.03% | +27.3% |
| Q2 2018 | $4,680,000 | – | 119,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |